memo-therapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /check/ Disallow: /contao/ Disallow: /system/ Disallow: /templates/ Disallow: /vendor/ Disallow: /share/index.php Disallow: /build.xml Disallow: /composer.json Disallow: /composer.lock Disallow: /README.md Allow: /system/cron/cron.txt Allow: /system/modules/*/assets/ Allow: | ||
Meta Tags
| Title | Home - Memo Therapeutics |
| Description | ABOUT MEMO THERAPEUTICS Skip navigation Home Pipeline Technology Skip navigation Home Pipeline Technology People Careers News Contact Skip navigation People Careers News Contact |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 149.126.6.13 |
| Location | Switzerland |
Related Websites
| Site | Rank |
More to Explore
memo-therapeutics.com Valuation
|
US$5,226,257
Last updated: 2023-05-02 22:40:58
memo-therapeutics.com has Semrush global rank of 2,025,217. memo-therapeutics.com has an estimated worth of US$ 5,226,257, based on its estimated Ads revenue. memo-therapeutics.com receives approximately 603,030 unique visitors each day. Its web server is located in Switzerland, with IP address 149.126.6.13. According to SiteAdvisor, memo-therapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,226,257 |
| Daily Ads Revenue | US$4,825 |
| Monthly Ads Revenue | US$144,728 |
| Yearly Ads Revenue | US$1,736,726 |
| Daily Unique Visitors | 40,202 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| memo-therapeutics.com. | A | 299 | IP: 149.126.6.13 |
| memo-therapeutics.com. | NS | 86400 | NS Record: ns1120.ui-dns.biz. |
| memo-therapeutics.com. | NS | 86400 | NS Record: ns1120.ui-dns.org. |
| memo-therapeutics.com. | NS | 86400 | NS Record: ns1120.ui-dns.com. |
| memo-therapeutics.com. | NS | 86400 | NS Record: ns1120.ui-dns.de. |
| memo-therapeutics.com. | MX | 3600 | MX Record: 0 memotherapeutics-com01b.mail.protection.outlook.com. |
| memo-therapeutics.com. | TXT | 3600 | TXT Record: v=spf1 ip4:62.12.134.158 include:spf.protection.outlook.com ~all |
| memo-therapeutics.com. | TXT | 3600 | TXT Record: google-site-verification=zQNGOR-d6FVEqlfuA7TXN00qLob3W8-P5JMRNRWNkc4 |
| memo-therapeutics.com. | TXT | 3600 | TXT Record: v=verifydomain MS=9166705 |
HtmlToTextCheckTime:2023-05-02 22:40:58
| Skip navigation Home Pipeline Technology Skip navigation Home Pipeline Technology People Careers News Contact Skip navigation People Careers News Contact ABOUT MEMO THERAPEUTICS AG Memo Therapeutics AG (”MTx”) is a late-stage biotech company developing best-in-class therapeutic antibodies to transform the lives of patients with virus infections and cancer. MTx’ lead program, AntiBKV, is a highly effective and safe neutralizing antibody to treat BK virus infection in kidney transplant recipients. This infection can lead to loss of kidney function, as well as organ failure and rejection. AntiBKV has completed Phase I clinical development and has started a pivotal multi-center, US Phase II/III study in 2023 with an efficacy readout by the end of 2023. MTx’ pipeline consists of additional therapeutic antibodies focusing on infectious diseases, such as cytomegalovirus (“CMV”), undisclosed immuno-oncology targets as well as a partnership with Ono Pharmaceutical. Technology Platform The |
HTTP Headers
HTTP/1.1 301 Moved Permanently Connection: Keep-Alive Date: Mon, 25 Oct 2021 06:32:59 GMT Location: https://memo-therapeutics.com/ HTTP/2 302 set-cookie: PHPSESSID=b44f8ed019c06615d61791812740380e; path=/; httponly; secure cache-control: no-cache, no-store, must-revalidate, max-age=0 location: https://memo-therapeutics.com/home.html referrer-policy: no-referrer-when-downgrade, strict-origin-when-cross-origin content-type: text/html; charset=UTF-8 date: Mon, 25 Oct 2021 06:33:00 GMT alt-svc: quic=":443"; ma=2592000; v="43,46", h3-Q043=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-25=":443"; ma=2592000, h3-27=":443"; ma=2592000 HTTP/2 200 set-cookie: PHPSESSID=24b4459d612f53e17103a9f35845f47a; path=/; httponly; secure cache-control: must-revalidate, no-cache, private content-type: text/html; charset=utf-8 vary: Contao-Page-Layout contao-page-layout: desktop x-content-type-options: nosniff referrer-policy: no-referrer-when-downgrade, strict-origin-when-cross-origin x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block content-length: 17079 date: Mon, 25 Oct 2021 06:33:00 GMT |
memo-therapeutics.com Whois Information
Domain Name: MEMO-THERAPEUTICS.COM Registry Domain ID: 1758577591_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ionos.com Registrar URL: http://www.ionos.com Updated Date: 2020-11-12T08:14:13Z Creation Date: 2012-11-11T12:01:20Z Registry Expiry Date: 2021-11-11T12:01:20Z Registrar: 1&1 IONOS SE Registrar IANA ID: 83 Registrar Abuse Contact Email: abuse@ionos.com Registrar Abuse Contact Phone: +1.6105601459 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1120.UI-DNS.BIZ Name Server: NS1120.UI-DNS.COM Name Server: NS1120.UI-DNS.DE Name Server: NS1120.UI-DNS.ORG DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T10:53:42Z <<< |